Pharma Mar, S.A.
0RC6.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.64B
Close$
Share Statistics
| Market cap | $1.64 Billion |
|---|---|
| Enterprise Value | $1.67 Billion |
| Dividend Yield | $1.00 (1.44%) |
| Earnings per Share | $0.06 |
| Beta | -0.04 |
| Outstanding Shares | 17,480,715 |
Return
| Return on Equity | 22.41% |
|---|---|
| Return on Assets | 14.28% |
| Return on Invested Capital | 12.02% |
Valuation & Multiples
| P/E Ratio | 21.28 |
|---|---|
| PEG | -20.43 |
| Price to Sales | 5.78 |
| Price to Book Ratio | 4.95 |
| Enterprise Value to Revenue | 7.62 |
| Enterprise Value to EBIT | 46.92 |
| Enterprise Value to Net Income | 29 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
$0.18
Average shareholder expectationRevenue Estimate
$44.20 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.06
Average shareholder expectationRevenue Estimate
$47.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Pharma Mar S.A.
515 employees
CEO: Jose Maria Fernandez Sousa-Faro Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, t...